EI
BIO icon

EAM Investors’s Bio-Rad Laboratories Class A BIO Stock Holding History

EAM Investors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-9,424
Closed -$2.13M – 294
2017
Q2 		$2.13M Sell
9,424
-5,152
-35% -$1.12M 0.35% 148
2017
Q1 		$2.91M Sell
14,576
-6,532
-31% -$1.26M 0.46% 92
2016
Q4 		$3.85M Buy
21,108
+3,115
+17% +$531K 0.51% 31
2016
Q3 		$2.95M Buy
+17,993
New +$2.73M 0.4% 96
2016
Q1 		– Sell
-24,370
Closed -$3.38M – 297
2015
Q4 		$3.38M Buy
24,370
+5,227
+27% +$725K 0.44% 82
2015
Q3 		$2.57M Sell
19,143
-4,449
-19% -$640K 0.41% 93
2015
Q2 		$3.55M Sell
23,592
-1,867
-7% -$267K 0.42% 81
2015
Q1 		$3.44M Buy
+25,459
New +$3.16M 0.4% 94

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

EAM Investors's BIO Position: Q3 2017 in Review

EAM Investors sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2017, closing a stake of 9,424 shares — an estimated $2.13M sold.

EAM Investors first reported a position in BIO in Q1 2015 and held it in 8 quarters. The position peaked at $3.85M in Q4 2016. 271 funds tracked by Wall St. Rank hold BIO as of Q3 2017.

  • EAM Investors reported no remaining Bio-Rad Laboratories Class A position as of Q3 2017 after selling out during the quarter.
  • EAM Investors sold 9,424 Bio-Rad Laboratories Class A shares in Q3 2017, an estimated $2.13M.
  • EAM Investors first reported a position in Bio-Rad Laboratories Class A in Q1 2015 and held it in 8 quarters.
  • EAM Investors's Bio-Rad Laboratories Class A position peaked at $3.85M in Q4 2016.
  • 271 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2017.

Based on EAM Investors's 13F filing for Q3 2017, filed 8 Nov 2017.